80 related articles for article (PubMed ID: 3813486)
1. Doxorubicin cytotoxicity to P388 lymphocytic leukemia as determined by alkaline elution and established assays.
Russo P; Favoni RE; Zarcone D; Miglietta L; Peluso M; Nicolin A; Bignone F; Parodi S
Anticancer Res; 1986; 6(6):1297-304. PubMed ID: 3813486
[TBL] [Abstract][Full Text] [Related]
2. [In vitro evaluation of the chemosensitivity of an experimental murine leukemia rendered resistant in vivo to adriamycin].
Lepri E; Menconi E; Barzi AM
Boll Soc Ital Biol Sper; 1984 Jul; 60(7):1369-75. PubMed ID: 6477749
[TBL] [Abstract][Full Text] [Related]
3. A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.
Mirabelli CK; Sung CM; McCabe FL; Faucette LF; Crooke ST; Johnson RK
Cancer Res; 1988 Oct; 48(19):5447-54. PubMed ID: 3046738
[TBL] [Abstract][Full Text] [Related]
4. Relationship between in vitro tumor stem cell assay and in vivo antitumor activity using the P388 leukemia.
Marsh JC; Shoemaker RH; Salmon SE; Kern DH; Venditti JM
Int J Cell Cloning; 1988 Jan; 6(1):60-8. PubMed ID: 3339266
[TBL] [Abstract][Full Text] [Related]
5. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
[TBL] [Abstract][Full Text] [Related]
6. Flow cytometric screening for selective toxicity to multidrug-resistant cells.
Frankfurt OS
J Natl Cancer Inst; 1987 Oct; 79(4):831-6. PubMed ID: 3477663
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity to anthracyclines in P388/dx leukaemia cells.
Bossa R; Dasdia T; Galatulas I; Zunino F
Anticancer Res; 1986; 6(5):1037-9. PubMed ID: 3099628
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the in vivo antitumor activity and in vitro cytotoxic properties of auranofin, a coordinated gold compound, in murine tumor models.
Mirabelli CK; Johnson RK; Sung CM; Faucette L; Muirhead K; Crooke ST
Cancer Res; 1985 Jan; 45(1):32-9. PubMed ID: 3917372
[TBL] [Abstract][Full Text] [Related]
9. Stability of the in vivo P388 leukemia model in evaluation of antitumor activity of natural products.
Marsh JC; Shoemaker RH; Suffness M
Cancer Treat Rep; 1985 Jun; 69(6):683-5. PubMed ID: 4016772
[TBL] [Abstract][Full Text] [Related]
10. Effects of quinidine and related compounds on cytotoxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells.
Tsuruo T; Iida H; Kitatani Y; Yokota K; Tsukagoshi S; Sakurai Y
Cancer Res; 1984 Oct; 44(10):4303-7. PubMed ID: 6467192
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine.
Ganapathi R; Grabowski D
Cancer Res; 1983 Aug; 43(8):3696-9. PubMed ID: 6861140
[TBL] [Abstract][Full Text] [Related]
12. Potentiation of antitumor activity of pirarubicin by chlorpromazine in mice bearing doxorubicin-resistant P388 leukemia.
Shibata H; Maekawa I; Furusawa S; Kawauchi H; Takayanagi Y; Sasaki K
Res Commun Chem Pathol Pharmacol; 1990 Dec; 70(3):359-62. PubMed ID: 2093213
[TBL] [Abstract][Full Text] [Related]
13. An in vitro assay for evaluating chemosensitivity of leukaemia cells: preclinical studies.
Menconi E; Lepri E; Bonmassar E; Frati L; Barzi A
Int J Tissue React; 1986; 8(6):485-92. PubMed ID: 3793386
[TBL] [Abstract][Full Text] [Related]
14. Effects of Dex-Verapamil on Doxorubicin cytotoxicity in P388 murine leukemia cells.
Noviello E; Allievi E; Russo P; Parodi S
Anticancer Drug Des; 1997 Jun; 12(4):261-76. PubMed ID: 9199659
[TBL] [Abstract][Full Text] [Related]
15. [A short term test suitable for in vitro prediction of the drug sensitivity of human leukemias: a preliminary study on murine experimental neoplasms].
Menconi E; Lepri E; Barzi AM
Boll Soc Ital Biol Sper; 1984 Feb; 60(2):413-9. PubMed ID: 6712803
[TBL] [Abstract][Full Text] [Related]
16. Oxygen radical detoxification enzymes in doxorubicin-sensitive and -resistant P388 murine leukemia cells.
Ramu A; Cohen L; Glaubiger D
Cancer Res; 1984 May; 44(5):1976-80. PubMed ID: 6324993
[TBL] [Abstract][Full Text] [Related]
17. Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells.
Ramu A; Glaubiger D; Magrath IT; Joshi A
Cancer Res; 1983 Nov; 43(11):5533-7. PubMed ID: 6311408
[TBL] [Abstract][Full Text] [Related]
18. Murine splenocyte migration inhibition assay I. Detection of differential responses to murine leukemia P388 and its adriamycin-resistant subline P388/ADR.
Nori M; Gothoskar BP
Neoplasma; 1983; 30(3):287-93. PubMed ID: 6223231
[TBL] [Abstract][Full Text] [Related]
19. Survival responses to new cytostatic hexitols of P388 mouse and K562 human leukemia cells in vitro.
Pályi I
Cancer Treat Rep; 1986 Feb; 70(2):279-84. PubMed ID: 3948192
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of doxorubicin and vinblastine sensitivity in anthracycline-resistant P388 cells.
Ramu A; Shan TC; Glaubiger D
Cancer Treat Rep; 1983 Oct; 67(10):895-9. PubMed ID: 6354437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]